| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
45,912 |
34,755 |
$1.79M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12,809 |
11,157 |
$1.02M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,928 |
8,874 |
$749K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
7,153 |
6,864 |
$590K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,963 |
8,508 |
$464K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
38,317 |
15,925 |
$442K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,750 |
2,728 |
$247K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,001 |
3,842 |
$222K |
| S8301 |
Infection control supplies, not otherwise specified |
18,127 |
14,920 |
$166K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,920 |
4,724 |
$150K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
17,809 |
17,267 |
$129K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,280 |
1,264 |
$124K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,608 |
1,577 |
$122K |
| 99460 |
|
1,625 |
1,594 |
$122K |
| 87634 |
|
1,708 |
1,623 |
$101K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,398 |
1,373 |
$86K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
15,359 |
13,173 |
$73K |
| 99381 |
|
889 |
879 |
$71K |
| 99462 |
|
999 |
975 |
$37K |
| 90461 |
|
4,560 |
4,149 |
$35K |
| 99383 |
|
258 |
249 |
$25K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
898 |
877 |
$24K |
| 36406 |
|
1,479 |
1,438 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
727 |
690 |
$9K |
| 99382 |
|
65 |
64 |
$6K |
| 0081A |
|
86 |
86 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
247 |
166 |
$3K |
| 0072A |
|
67 |
67 |
$3K |
| 81002 |
|
874 |
773 |
$3K |
| 0001A |
|
64 |
54 |
$2K |
| 0071A |
|
49 |
49 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
136 |
130 |
$2K |
| 99384 |
|
17 |
17 |
$2K |
| 96160 |
|
3,424 |
3,030 |
$1K |
| 96381 |
|
66 |
66 |
$1K |
| 0082A |
|
21 |
21 |
$818.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
64 |
63 |
$730.41 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$571.79 |
| 97802 |
|
47 |
47 |
$181.60 |
| 81001 |
|
15 |
12 |
$48.60 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
247 |
166 |
$8.33 |
| 90671 |
|
1,521 |
1,511 |
$4.68 |
| 90677 |
|
582 |
577 |
$4.01 |
| 90697 |
|
918 |
913 |
$1.52 |
| 90686 |
|
1,800 |
1,791 |
$0.94 |
| 91307 |
|
185 |
162 |
$0.44 |
| 91308 |
|
184 |
176 |
$0.29 |
| 90651 |
|
555 |
547 |
$0.24 |
| 90380 |
|
71 |
70 |
$0.10 |
| 90619 |
|
61 |
61 |
$0.10 |
| 90658 |
|
985 |
980 |
$0.09 |
| 90381 |
|
74 |
72 |
$0.06 |
| 91300 |
|
88 |
69 |
$0.05 |
| 90620 |
|
82 |
80 |
$0.05 |
| 90656 |
|
262 |
262 |
$0.04 |
| 90707 |
|
2,245 |
2,229 |
$0.02 |
| 90700 |
|
1,433 |
1,426 |
$0.01 |
| 90734 |
|
229 |
226 |
$0.01 |
| 90633 |
|
3,228 |
3,206 |
$0.01 |
| 90670 |
|
4,728 |
4,689 |
$0.01 |
| 90681 |
|
216 |
216 |
$0.01 |
| 90744 |
|
2,541 |
2,523 |
$0.01 |
| 90716 |
|
2,254 |
2,238 |
$0.01 |
| 90715 |
|
49 |
48 |
$0.00 |
| 99173 |
|
5,327 |
5,274 |
$0.00 |
| 90710 |
|
352 |
349 |
$0.00 |
| 90649 |
|
26 |
26 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
46 |
45 |
$0.00 |
| 90648 |
|
18 |
18 |
$0.00 |
| 94664 |
|
19 |
19 |
$0.00 |
| 90655 |
|
50 |
47 |
$0.00 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
383 |
375 |
$0.00 |
| 90680 |
|
4,951 |
4,915 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,371 |
2,349 |
$0.00 |
| 90647 |
|
1,369 |
1,363 |
$0.00 |
| 90696 |
|
905 |
891 |
$0.00 |
| 90698 |
|
4,490 |
4,461 |
$0.00 |
| 96127 |
|
136 |
135 |
$0.00 |
| 90688 |
|
13 |
13 |
$0.00 |